Escondido, CA, United States of America

Matthew Moyle


Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 89(Granted Patents)


Location History:

  • Boulder, CA (US) (2000)
  • Thousand Oaks, CA (US) (2004)
  • Escondido, CA (US) (1998 - 2005)
  • Boulder, CO (US) (2000 - 2005)

Company Filing History:


Years Active: 1998-2005

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Matthew Moyle: Innovator in Immunotherapy

Introduction

Matthew Moyle, based in Escondido, California, is an accomplished inventor with a remarkable portfolio of 20 patents. His work primarily focuses on innovations in immunotherapy, particularly in the form of compositions that target neutrophil activity. Moyle's inventions have contributed significantly to the field of medicine, aiming to improve therapeutic approaches to inflammatory conditions.

Latest Patents

Among his latest patents, Moyle has developed compositions enriched for Neutrophil Inhibitory Factor. These compositions are designed to inhibit neutrophil activity, including their adhesion to vascular endothelial cells. Moreover, he has created recombinant Neutrophil Inhibitory Factors that also serve this purpose. Such innovations are crucial for therapies addressing abnormal or undesired inflammatory responses. Additionally, he holds patents on nematode-extracted serine protease inhibitors and anticoagulant proteins. These proteins, characterized by having at least one NAP domain, can exhibit factor Xa inhibitory activity and inhibit factor VIIa/TF. They can be isolated from natural sources like nematodes or produced through chemical synthesis or recombinant DNA techniques.

Career Highlights

Moyle has built his career by working with reputable companies in the biotechnology sector. Notably, he has contributed to Corvas International, Inc. and Dendreon Corporation. His work in these organizations has been instrumental in advancing research and development in therapeutic interventions.

Collaborations

Throughout his career, Moyle has collaborated with esteemed professionals in the field, including George Phillip Vlasuk and Yves Rene LaRoche. These partnerships have fostered significant advancements in the research and development of innovative therapeutic methods.

Conclusion

Matthew Moyle stands out as a prolific inventor in the medical field, with numerous patents that highlight his innovative contributions to immunotherapy. His strategic collaborations and work with leading companies continue to influence the landscape of therapeutic science, paving the way for advancements that address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…